The Glucose Measurement Industry and Hemoglobin A1c: An Opportunity for Creative Destruction. (January 2016)

• Record Type: Journal Article
• Authors: Cembrowski, George
• Is Part Of: Journal of diabetes science and technology. Volume 10:Number 1(2016:Jan.)
• Page Start: 72
• Page End: 75
• Publication Date: 2016-01
• Subjects: hemoglobin A1c -- glucose -- calculated HbA1c -- anemia; Diabetes -- Periodicals; Medical technology -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1177/1932296815610779
• Languages: English
• ISSNs: 1932-2968

Abstract

The MyStar Extra self-monitoring blood glucose (SMBG) system provides moving estimates of the patient's hemoglobin A1c (HbA1c). There is a treasure trove of highly accurate glucose data available from highly accurate SMBG, CGM and FGM along with highly accurate HPLC HbA1c. If Nathan's criteria are used to select subjects whose glucoses can be correlated to the HbA1c, then algorithms can be developed for robustly transforming glucose into HbA1c. These algorithms can then be implemented in any SMBG or with the CGM and FGM software. This calculated HbA1c would even be accurate with Nathan's excluded population thus reducing the use of fructosamine and glycated protein. Finally, the developer of these new algorithms is advised to use a specific approach for testing her algorithm.